Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

CADENCE PHARMACEUTICALS INC (CADX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $6.19 Metrics
OS: 89.2 M -70 % ROE
Market cap: $552 M
Net cash: $28.1 M $0.31 per share
EV: $524 M

 
TTM Valuation
EBITDA ($26.0) M
EBIT ($27.5) M
EPS ($0.28)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
Revenues112.650.216.70.00.040.041.847.8
            Revenue growth124.3%200.6%  -100.0%-4.2%-12.6%-99.2%
Cost of goods sold38.023.312.40.00.040.041.847.8
Gross profit74.626.94.30.00.00.00.00.0
            Gross margin66.3%53.7%25.7%  0.0%0.0%0.0%
Selling, general and administrative94.586.881.539.324.6   
Sales and marketing     3.02.90.8
Research and development6.76.58.913.819.5   
General and administrative     11.19.64.9
EBITA-26.2-67.6-86.0-53.4-44.5-56.5-54.2-53.6
            EBITA margin-23.3%-134.7%-515.3%  -141.3%-129.8%-112.0%
Amortization of intangibles1.31.31.6     
EBIT-27.5-69.0-87.6-53.4-44.5-56.5-54.2-53.6
            EBIT margin-24.5%-137.4%-524.7%  -141.3%-129.8%-112.0%
Pre-tax income-24.3-81.0-93.0-56.6-45.5-57.1-51.7-52.2
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-24.3-81.0-93.0-56.6-45.5-57.1-51.7-52.2
            Net margin-21.6%-161.4%-557.1%  -142.7%-123.8%-109.1%
 
Diluted EPS($0.28)($0.95)($1.41)($1.09)($0.93)($1.55)($1.81)($10.07)
Shares outstanding (diluted)86.085.666.152.048.836.828.65.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy